Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 7/20 | 0.88 |
| ▸ | CNR1 | P21554 | 3/20 | 0.88 |
| ▸ | CNR2 | P34972 | 3/20 | 0.88 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.88 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.88 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.88 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.88 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.88 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.88 |
| ▸ | TRPV3 | Q8NET8 | 2/20 | 0.88 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.88 |
| ▸ | TRPV2 | Q9Y5S1 | 2/20 | 0.88 |
| ▸ | INHA | P05111 | 1/20 | 0.88 |
| ▸ | HTR2A | P28223 | 1/20 | 0.88 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.88 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.88 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.56 |
| ▸ | TRPM7 | Q96QT4 | 1/20 | 0.56 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cannabigerol SCHEMBL12954626 | 0.93 | PPARG (1.00) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| Cannabigerol SCHEMBL14764730 | 0.93 | PPARG (1.00) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| Cannabigerol SCHEMBL144819 | 0.93 | PPARG (1.00) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523554 | 0.92 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523493 | 0.92 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523558 | 0.92 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523451 | 0.92 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523642 | 0.92 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523040 | 0.92 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523547 | 0.92 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070027144-A1 | Novel use of cannabinoid receptor agonist | SHIONOGI & CO., LTD. (JP) | 2007-02-01 | — | — | US | disclosed |
| US-20070027144-A1 | Novel use of cannabinoid receptor agonist | SHIONOGI & CO., LTD. (JP) | 2007-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070027144-A1 | Novel use of cannabinoid receptor agonist | CNR2, CNR1, OPRM1 | PPARG 209/4885CNR1 2/4885CNR2 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.